Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
2
RMTI Quote, Financials, Valuation and Earnings
Last price:
$0.90
Seasonality move
:
2.08%
Day range:
$0.89 - $0.94
52-week range:
$0.78 - $2.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.41x
P/B ratio:
0.96x
Volume:
265.4K
Avg. volume:
1.2M
1-year change:
-44.75%
Market cap:
$35.5M
Revenue:
$101.5M
EPS (TTM):
-$0.16
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RMTI
Rockwell Medical, Inc.
|
$18.5M | $0.04 | -2.95% | -- | $3.75 |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
-- | -$0.15 | -- | -7.79% | $33.33 |
|
GERN
Geron Corp.
|
$54.2M | -$0.01 | 26.52% | -32.89% | $3.40 |
|
JAGX
Jaguar Health, Inc.
|
$4.2M | -$1.49 | 20.18% | -92.94% | $7.50 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.6M | -$0.03 | 22.78% | -97.49% | $5.50 |
|
RAPT
Rapt Therapeutics, Inc.
|
-- | -$0.74 | -- | -740.65% | $58.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RMTI
Rockwell Medical, Inc.
|
$0.90 | $3.75 | $35.5M | -- | $0.00 | 0% | 0.41x |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$18.26 | $33.33 | $1.5B | -- | $0.00 | 0% | -- |
|
GERN
Geron Corp.
|
$1.68 | $3.40 | $1.1B | -- | $0.00 | 0% | 6.09x |
|
JAGX
Jaguar Health, Inc.
|
$0.89 | $7.50 | $1.1M | -- | $0.00 | 0% | 0.31x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.30 | $5.50 | $41.6M | -- | $0.00 | 0% | 4.85x |
|
RAPT
Rapt Therapeutics, Inc.
|
$57.98 | $58.00 | $958.9M | -- | $0.00 | 0% | 54.16x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RMTI
Rockwell Medical, Inc.
|
26.17% | 1.942 | 27.76% | 3.34x |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
1.39% | 3.396 | 0.18% | 8.14x |
|
GERN
Geron Corp.
|
-- | 1.656 | -- | 3.16x |
|
JAGX
Jaguar Health, Inc.
|
85.01% | -1.055 | 766.14% | 0.14x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
|
RAPT
Rapt Therapeutics, Inc.
|
1.68% | 3.419 | 0.61% | 11.76x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RMTI
Rockwell Medical, Inc.
|
$2.3M | -$1.6M | -12.07% | -17.16% | -9.95% | -$1.5M |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
-$28K | -$10.6M | -30.03% | -30.6% | -- | -$9.6M |
|
GERN
Geron Corp.
|
$46.7M | -$10.8M | -18.85% | -33.5% | -22.47% | -$13.5M |
|
JAGX
Jaguar Health, Inc.
|
$2M | -$7.2M | -97.4% | -524.57% | -234.77% | -$4.7M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
|
RAPT
Rapt Therapeutics, Inc.
|
-$200K | -$19.4M | -66.16% | -67.79% | -- | -$12.5M |
Rockwell Medical, Inc. vs. Competitors
-
Which has Higher Returns RMTI or CRVS?
Corvus Pharmaceuticals, Inc. has a net margin of -11.01% compared to Rockwell Medical, Inc.'s net margin of --. Rockwell Medical, Inc.'s return on equity of -17.16% beat Corvus Pharmaceuticals, Inc.'s return on equity of -30.6%.
Company Gross Margin Earnings Per Share Invested Capital RMTIRockwell Medical, Inc.14.27% -$0.05 $50.1M CRVSCorvus Pharmaceuticals, Inc.-- -$0.12 $72.8M -
What do Analysts Say About RMTI or CRVS?
Rockwell Medical, Inc. has a consensus price target of $3.75, signalling upside risk potential of 316.39%. On the other hand Corvus Pharmaceuticals, Inc. has an analysts' consensus of $33.33 which suggests that it could grow by 91.68%. Given that Rockwell Medical, Inc. has higher upside potential than Corvus Pharmaceuticals, Inc., analysts believe Rockwell Medical, Inc. is more attractive than Corvus Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RMTIRockwell Medical, Inc.1 0 0 CRVSCorvus Pharmaceuticals, Inc.6 0 0 -
Is RMTI or CRVS More Risky?
Rockwell Medical, Inc. has a beta of 1.705, which suggesting that the stock is 70.461% more volatile than S&P 500. In comparison Corvus Pharmaceuticals, Inc. has a beta of 0.731, suggesting its less volatile than the S&P 500 by 26.895%.
-
Which is a Better Dividend Stock RMTI or CRVS?
Rockwell Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Corvus Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Rockwell Medical, Inc. pays -- of its earnings as a dividend. Corvus Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMTI or CRVS?
Rockwell Medical, Inc. quarterly revenues are $15.9M, which are larger than Corvus Pharmaceuticals, Inc. quarterly revenues of --. Rockwell Medical, Inc.'s net income of -$1.8M is higher than Corvus Pharmaceuticals, Inc.'s net income of -$10.2M. Notably, Rockwell Medical, Inc.'s price-to-earnings ratio is -- while Corvus Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rockwell Medical, Inc. is 0.41x versus -- for Corvus Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMTIRockwell Medical, Inc.0.41x -- $15.9M -$1.8M CRVSCorvus Pharmaceuticals, Inc.-- -- -- -$10.2M
-
Which has Higher Returns RMTI or GERN?
Geron Corp. has a net margin of -11.01% compared to Rockwell Medical, Inc.'s net margin of -64.86%. Rockwell Medical, Inc.'s return on equity of -17.16% beat Geron Corp.'s return on equity of -33.5%.
Company Gross Margin Earnings Per Share Invested Capital RMTIRockwell Medical, Inc.14.27% -$0.05 $50.1M GERNGeron Corp.97.28% -$0.05 $223.6M -
What do Analysts Say About RMTI or GERN?
Rockwell Medical, Inc. has a consensus price target of $3.75, signalling upside risk potential of 316.39%. On the other hand Geron Corp. has an analysts' consensus of $3.40 which suggests that it could grow by 102.38%. Given that Rockwell Medical, Inc. has higher upside potential than Geron Corp., analysts believe Rockwell Medical, Inc. is more attractive than Geron Corp..
Company Buy Ratings Hold Ratings Sell Ratings RMTIRockwell Medical, Inc.1 0 0 GERNGeron Corp.3 1 1 -
Is RMTI or GERN More Risky?
Rockwell Medical, Inc. has a beta of 1.705, which suggesting that the stock is 70.461% more volatile than S&P 500. In comparison Geron Corp. has a beta of 0.620, suggesting its less volatile than the S&P 500 by 38.038%.
-
Which is a Better Dividend Stock RMTI or GERN?
Rockwell Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Geron Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Rockwell Medical, Inc. pays -- of its earnings as a dividend. Geron Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMTI or GERN?
Rockwell Medical, Inc. quarterly revenues are $15.9M, which are smaller than Geron Corp. quarterly revenues of $48M. Rockwell Medical, Inc.'s net income of -$1.8M is higher than Geron Corp.'s net income of -$31.1M. Notably, Rockwell Medical, Inc.'s price-to-earnings ratio is -- while Geron Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rockwell Medical, Inc. is 0.41x versus 6.09x for Geron Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMTIRockwell Medical, Inc.0.41x -- $15.9M -$1.8M GERNGeron Corp.6.09x -- $48M -$31.1M
-
Which has Higher Returns RMTI or JAGX?
Jaguar Health, Inc. has a net margin of -11.01% compared to Rockwell Medical, Inc.'s net margin of -312.94%. Rockwell Medical, Inc.'s return on equity of -17.16% beat Jaguar Health, Inc.'s return on equity of -524.57%.
Company Gross Margin Earnings Per Share Invested Capital RMTIRockwell Medical, Inc.14.27% -$0.05 $50.1M JAGXJaguar Health, Inc.64.58% -$6.28 $36.3M -
What do Analysts Say About RMTI or JAGX?
Rockwell Medical, Inc. has a consensus price target of $3.75, signalling upside risk potential of 316.39%. On the other hand Jaguar Health, Inc. has an analysts' consensus of $7.50 which suggests that it could grow by 744.69%. Given that Jaguar Health, Inc. has higher upside potential than Rockwell Medical, Inc., analysts believe Jaguar Health, Inc. is more attractive than Rockwell Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RMTIRockwell Medical, Inc.1 0 0 JAGXJaguar Health, Inc.0 0 0 -
Is RMTI or JAGX More Risky?
Rockwell Medical, Inc. has a beta of 1.705, which suggesting that the stock is 70.461% more volatile than S&P 500. In comparison Jaguar Health, Inc. has a beta of 0.092, suggesting its less volatile than the S&P 500 by 90.778%.
-
Which is a Better Dividend Stock RMTI or JAGX?
Rockwell Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jaguar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Rockwell Medical, Inc. pays -- of its earnings as a dividend. Jaguar Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMTI or JAGX?
Rockwell Medical, Inc. quarterly revenues are $15.9M, which are larger than Jaguar Health, Inc. quarterly revenues of $3.1M. Rockwell Medical, Inc.'s net income of -$1.8M is higher than Jaguar Health, Inc.'s net income of -$9.6M. Notably, Rockwell Medical, Inc.'s price-to-earnings ratio is -- while Jaguar Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rockwell Medical, Inc. is 0.41x versus 0.31x for Jaguar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMTIRockwell Medical, Inc.0.41x -- $15.9M -$1.8M JAGXJaguar Health, Inc.0.31x -- $3.1M -$9.6M
-
Which has Higher Returns RMTI or PSTV?
Plus Therapeutics, Inc. has a net margin of -11.01% compared to Rockwell Medical, Inc.'s net margin of -316.61%. Rockwell Medical, Inc.'s return on equity of -17.16% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RMTIRockwell Medical, Inc.14.27% -$0.05 $50.1M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About RMTI or PSTV?
Rockwell Medical, Inc. has a consensus price target of $3.75, signalling upside risk potential of 316.39%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1716.98%. Given that Plus Therapeutics, Inc. has higher upside potential than Rockwell Medical, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than Rockwell Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RMTIRockwell Medical, Inc.1 0 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is RMTI or PSTV More Risky?
Rockwell Medical, Inc. has a beta of 1.705, which suggesting that the stock is 70.461% more volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock RMTI or PSTV?
Rockwell Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Rockwell Medical, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMTI or PSTV?
Rockwell Medical, Inc. quarterly revenues are $15.9M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. Rockwell Medical, Inc.'s net income of -$1.8M is higher than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, Rockwell Medical, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rockwell Medical, Inc. is 0.41x versus 4.85x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMTIRockwell Medical, Inc.0.41x -- $15.9M -$1.8M PSTVPlus Therapeutics, Inc.4.85x -- $1.4M -$4.4M
-
Which has Higher Returns RMTI or RAPT?
Rapt Therapeutics, Inc. has a net margin of -11.01% compared to Rockwell Medical, Inc.'s net margin of --. Rockwell Medical, Inc.'s return on equity of -17.16% beat Rapt Therapeutics, Inc.'s return on equity of -67.79%.
Company Gross Margin Earnings Per Share Invested Capital RMTIRockwell Medical, Inc.14.27% -$0.05 $50.1M RAPTRapt Therapeutics, Inc.-- -$0.65 $154.6M -
What do Analysts Say About RMTI or RAPT?
Rockwell Medical, Inc. has a consensus price target of $3.75, signalling upside risk potential of 316.39%. On the other hand Rapt Therapeutics, Inc. has an analysts' consensus of $58.00 which suggests that it could grow by 0.04%. Given that Rockwell Medical, Inc. has higher upside potential than Rapt Therapeutics, Inc., analysts believe Rockwell Medical, Inc. is more attractive than Rapt Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RMTIRockwell Medical, Inc.1 0 0 RAPTRapt Therapeutics, Inc.0 9 0 -
Is RMTI or RAPT More Risky?
Rockwell Medical, Inc. has a beta of 1.705, which suggesting that the stock is 70.461% more volatile than S&P 500. In comparison Rapt Therapeutics, Inc. has a beta of 0.468, suggesting its less volatile than the S&P 500 by 53.241%.
-
Which is a Better Dividend Stock RMTI or RAPT?
Rockwell Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Rapt Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Rockwell Medical, Inc. pays -- of its earnings as a dividend. Rapt Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RMTI or RAPT?
Rockwell Medical, Inc. quarterly revenues are $15.9M, which are larger than Rapt Therapeutics, Inc. quarterly revenues of --. Rockwell Medical, Inc.'s net income of -$1.8M is higher than Rapt Therapeutics, Inc.'s net income of -$17.6M. Notably, Rockwell Medical, Inc.'s price-to-earnings ratio is -- while Rapt Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Rockwell Medical, Inc. is 0.41x versus 54.16x for Rapt Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RMTIRockwell Medical, Inc.0.41x -- $15.9M -$1.8M RAPTRapt Therapeutics, Inc.54.16x -- -- -$17.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Feb 28
Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.
Buy
90
BNAI alert for Feb 28
Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.
Sell
36
WLDN alert for Feb 28
Willdan Group, Inc. [WLDN] is down 25.56% over the past day.
